Do the results of your analysis make the case for existing Neuren shareholders to consider also taking a position in Acadia now, because (subject to the risks of the acquiror being a different entity), Acadia is the likely suitor, and NNZ-2591 would not be subject to anyone’s consent rights post acquisition, which would increase the value of NNZ-2591?
- Forums
- ASX - By Stock
- Ann: Q2 2023 quarterly activity and cash flow report
Do the results of your analysis make the case for existing...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.97 |
Change
0.000(0.00%) |
Mkt cap ! $2.552B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 111 | $20.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.98 | 232 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 33 | 20.960 |
1 | 190 | 20.030 |
2 | 746 | 20.000 |
1 | 231 | 19.990 |
2 | 39 | 19.970 |
Price($) | Vol. | No. |
---|---|---|
18.980 | 232 | 1 |
19.380 | 10 | 2 |
19.770 | 89 | 5 |
19.960 | 18 | 1 |
19.970 | 1142 | 2 |
Last trade - 10.02am 05/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable